| 1 |
Azithromycin FDA Label
|
| 2 |
FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (ANDA) 065511.
|
| 3 |
ClinicalTrials.gov (NCT04332107) Azithromycin for COVID-19 Treatment in Outpatients Nationwide. U.S. National Institutes of Health.
|
| 4 |
Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
|
| 5 |
Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019101)
|
| 6 |
ClinicalTrials.gov (NCT04202380) Azithromycin for Preterm Pre-labor Rupture of Membranes
|
| 7 |
ClinicalTrials.gov (NCT00379821) Chloroquine Alone or in Combination for Malaria in Children in Malawi
|
| 8 |
ClinicalTrials.gov (NCT00983294) Drug-Drug Interaction Study of Colchicine and Azithromycin
|
| 9 |
ClinicalTrials.gov (NCT01072136) Empiric Therapy of Mucopurulent Cervicitis (MPC)
|
| 10 |
ClinicalTrials.gov (NCT01100060) A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects
|
| 11 |
ClinicalTrials.gov (NCT01721616) Comparison Study of Cefazolin Versus Cefazolin Plus Azithromycin Prophylaxis in Post-Cesarean Endometritis
|
| 12 |
ClinicalTrials.gov (NCT03801252) Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term
|
| 13 |
ClinicalTrials.gov (NCT03098485) Healthy Patients & Effect of Antibiotics
|
| 14 |
ClinicalTrials.gov (NCT01150747) Chlamydia Trachomatis Immunology and Vaccinology Study
|
| 15 |
ClinicalTrials.gov (NCT01464125) Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults
|
| 16 |
ClinicalTrials.gov (NCT00926796) Efficacy of Combination Therapies for Gonorrhea Treatment
|
| 17 |
ClinicalTrials.gov (NCT01618591) Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea
|
| 18 |
ClinicalTrials.gov (NCT05842681) Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis
|
| 19 |
ClinicalTrials.gov (NCT04457609) Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients
|
| 20 |
ClinicalTrials.gov (NCT01272635) Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.
|
| 21 |
ClinicalTrials.gov (NCT00598962) Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease
|
| 22 |
ClinicalTrials.gov (NCT00322465) NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)
|
| 23 |
ClinicalTrials.gov (NCT04322396) Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19
|
| 24 |
ClinicalTrials.gov (NCT03960970) Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries
|
| 25 |
ClinicalTrials.gov (NCT04186247) Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)
|
| 26 |
ClinicalTrials.gov (NCT04347031) An Open Randomized Study of the Effectiveness of Mefloquine for the Treatment of Patients With COVID19. U.S. National Institutes of Health.
|
| 27 |
ClinicalTrials.gov (NCT04339426) Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection. U.S. National Institutes of Health.
|
| 28 |
ClinicalTrials.gov (NCT03672630) Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
|
| 29 |
ClinicalTrials.gov (NCT04459702) A Study of Combination Therapies to Treat COVID-19 Infection
|
| 30 |
ClinicalTrials.gov (NCT03060473) Treatment of ppROM With Erythromycin vs. Azithromycin Trial
|
| 31 |
ClinicalTrials.gov (NCT04328272) Effectiveness of Hydroxychloroquine in Covid-19 Patients
|
| 32 |
ClinicalTrials.gov (NCT02754583) Sanitation, Water, and Instruction in Face-washing for Trachoma I/II
|
| 33 |
ClinicalTrials.gov (NCT03474276) Comparing Several Strategies to Manage Moderate Acute Malnutrition Among Children From 6 to 24 Months Old
|
| 34 |
ClinicalTrials.gov (NCT04321278) Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II). U.S. National Institutes of Health.
|
| 35 |
ClinicalTrials.gov (NCT04371406) Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients. U.S. National Institutes of Health.
|
| 36 |
ClinicalTrials.gov (NCT02210325) Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea
|
| 37 |
ClinicalTrials.gov (NCT04528927) Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia
|
| 38 |
ClinicalTrials.gov (NCT04613271) Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia
|
| 39 |
ClinicalTrials.gov (NCT04338698) Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT
|
| 40 |
ClinicalTrials.gov (NCT03032042) Intestinal Microbiome Post-Azythromycin/Albendazole Treatment
|
| 41 |
ClinicalTrials.gov (NCT02677701) Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF)
|
| 42 |
ClinicalTrials.gov (NCT05677282) Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct
|
| 43 |
ClinicalTrials.gov (NCT01820026) Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis
|
| 44 |
ClinicalTrials.gov (NCT00035347) Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia
|
| 45 |
ClinicalTrials.gov (NCT02775617) Azithromycin - Ivermectin Mass Drug Administration for Skin Disease
|
| 46 |
ClinicalTrials.gov (NCT04370782) Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting
|
|
|
|
|
|
|
